Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b>Barbara A. Spruce, Suzanne A. Eccles, N. McTavish et al.|Cancer Research|2004Cited by 165
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinomaStephen A. Watt, Andrew P. South|Oncogene|2011Cited by 77